Related Articles
Molecular alterations in clinical stage III cutaneous melanoma: Correlation with clinicopathological features and patient outcome
Effects of BRAF V600E and NRAS mutational status on the progression‑free survival and clinicopathological characteristics of patients with melanoma
A population‑based study of outcomes in patients with surgically resected non‑small cell lung cancer with anaplastic lymphoma kinase‑rearranged mutations: A matched‑pair study
Expression of CD44s and CD44 splice variants in human melanoma
Evaluation of P53 immunostaining in patients with cutaneous melanoma